Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde 3-phosphate dehydrogenase pseudogene 46 (GAPDHP46) is a genomic sequence highly homologous to the functional enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), but it does not encode a functional protein and lacks biological activity characteristic of GAPDH[6][8]. GAPDHP46 is one of many GAPDH-related pseudogenes present in the human genome[2][8]. These pseudogenes are generally unexpressed and are not implicated in normal physiology or disease pathogenesis[6][8]. The functional GAPDH protein is a classic glycolytic enzyme, but GAPDHP46 itself does not contribute to metabolic or regulatory pathways[6][8]. Pseudogenes such as GAPDHP46 arise from duplication or retrotransposition events, resulting in DNA sequences that are similar to active genes but typically not transcribed or translated into protein[4][8]. Human and mouse genomes contain dozens to hundreds of GAPDH pseudogenes[2][8]. Functional confusion may arise in qPCR/RT-PCR experiments if primers are not specific enough, as GAPDH pseudogenes can be misamplified[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde 3-phosphate dehydrogenase pseudogene 46 (GAPDHP46).